News

Article

Corza Medical opens its Ophthalmology Center of Technology and Innovation

Author(s):

The center includes about 30,000 square feet of space for rapid prototyping of new product designs, enhance manufacturing capabilities, and the expansion of research and development capabilities.

Corza Medical’s Ophthalmology Center of Technology and Innovation in Fenton, Missouri. (Image courtesy of Corza Medical)

Corza Medical’s Ophthalmology Center of Technology and Innovation in Fenton, Missouri. (Image courtesy of Corza Medical)

Corza Medical is debuting its new Ophthalmology Center of Technology and Innovation designed to advance the development of next-generation devices for ophthalmic surgeries and other eye treatments.

The company, which is headquartered in Westwood, Massachusetts, noted in a news release the new facility, located in Fenton, Missouri, includes about 30,000 square feet of space for rapid prototyping of new product designs, enhanced manufacturing capabilities, and the expansion of research and development capabilities.

In a news release, Corza Medical CEO Tom Testa, the facility offers opportunity for the company.

“We are thrilled to announce the opening of our new Ophthalmology Center of Technology and Innovation,” he said in a news release. “This investment is a testament to our commitment to advancing medical technology and developing solutions that improve treatment and care for patients."

Moreover, Corza Medical Executive Chairman Gregory T Lucier pointed out the facility will improve the ability to work with surgeons and customers.

“This new center will allow us to work closely with surgeons and other customers to better understand their needs and develop innovative solutions that address their specific challenges,” he explained in the news release.

Lucier added that over the next 3 years, the center is expected to create 80 new jobs, including roles in manufacturing, research and development, and various technical and support positions.

“The onsite meeting facilities will also facilitate collaboration between surgeons and other customers with Corza experts to share insights and ideas,” he concluded.

Arsham Sheybani, MD, an advanced anterior segment and glaucoma surgeon, shared his experience with the ophthalmology team at Corza Medical.

“I've been working with the ophthalmology team at Corza Medical for the last several years, having a front-row seat to seeing them innovate beyond their core Katena instrumentation into surgical lenses like the SensorTek hands-free gonio lens line and beyond,” he said in the company’s news release. “I'm so pleased and excited to see them expand their manufacturing and technology footprint in St. Louis by opening this new center of technology and innovation, and I see it as a reflection of their commitment to ophthalmology and continued investment in the St. Louis community.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.